showing 1943 abstracts from year 2018
filter abstracts
| Details |
title |
year |
| Details |
PL02.03 BRIGATINIB VS CRIZOTINIB IN PATIENTS WITH ALK INHIBITOR-NAIVE ADVA... |
2018 |
| Details |
PL03.06 THE FUTURE OF TARGETED THERAPY... |
2018 |
| Details |
PL03.05 IT’S ALL IN THE TISSUE... |
2018 |
| Details |
ES01.02 IMAGE INTERPRETATION AND ADVANCES FROM THE PERSPECTIVE OF THE RADI... |
2018 |
| Details |
ES01.01 IMAGE QUALITY CHARACTERISTICS AND NODULE GROWTH MEASUREMENT, MEDIC... |
2018 |
| Details |
ES01.03 DEEP MACHINE LEARNING FOR SCREENING LDCT... |
2018 |
| Details |
ES01.04 MULTI-PHASIC SCREENING - CAN WE ADDRESS COMPETING CAUSES OF MORBID... |
2018 |
| Details |
ES02.02 PRO: TO MEDICATE: MANAGING BREATHLESSNESS... |
2018 |
| Details |
ES02.03 CON: NOT TO MEDICATE: MANAGING BREATHLESSNESS... |
2018 |
| Details |
ES02.01 EXPANDING PROS IN DAILY PRACTICE... |
2018 |
| Details |
ES02.04 MOLECULAR TESTING 101 FOR NURSES... |
2018 |
| Details |
ES02.05 STRUCTURED APPROACH FOR DEVELOPING AND IMPLEMENTING AND ADVANCED P... |
2018 |
| Details |
ES03.03 WHEN TO REPEAT PLEURAL BIOPSIES... |
2018 |
| Details |
ES03.04 ROLE OF CHEMOTHERAPY IN MESOTHELIOMA WITH MINIMAL BULK DISEASE... |
2018 |
| Details |
ES03.01 DIAGNOSIS OF MESOTHELIOMA BASED ON CYTOLOGY ALONE... |
2018 |
| Details |
ES03.05 ROLE OF SURGERY IN T0 MESOTHELIOMA... |
2018 |
| Details |
ES04.03 OVERCOMING RESISTANCE BY IMPROVING TREATMENT COMPLIANCE... |
2018 |
| Details |
ES04.01 LIQUID BIOPSIES IN LUNG CANCER... |
2018 |
| Details |
ES05.02 CAN PATIENT GROUPS AND REGULATORY BODIES WORK TOGETHER TO MAKE CLI... |
2018 |
| Details |
ES05.04 CHALLENGES AND SOLUTIONS IN ENGAGING WITH THE HEALTH TECHNOLOGY AS... |
2018 |
1 2 3 4 5 6 7 8 ...98 Next